34
Participants
Start Date
January 12, 2023
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2026
Biopsy
Undergo biopsy
Biospecimen Collection
Correlative studies
Extended Release Metformin Hydrochloride
Given PO
Placebo Administration
Given PO
NYU College of Dentistry, New York
Emory University Hospital/Winship Cancer Institute, Atlanta
Moffitt Cancer Center, Tampa
University of Michigan Comprehensive Cancer Center, Ann Arbor
University of Minnesota/Masonic Cancer Center, Minneapolis
Louisiana State University, Lafayette
University of Arizona Cancer Center-North Campus, Tucson
UC San Diego Medical Center - Hillcrest, San Diego
British Columbia Cancer Agency, Vancouver
Dalhousie University, Halifax
National Cancer Institute (NCI)
NIH
University of Arizona
OTHER